Device Aimed at Early Detection of Deadly Diseases Wins NJ Health Foundation Grant
The New Jersey Health Foundation has awarded an innovation grant to develop a nanotechnology-enhanced biochip to help detect deadly diseases.
Read MorePosted by Cassandra Perez | Nov 7, 2017 | Sexually Transmitted Diseases |
The New Jersey Health Foundation has awarded an innovation grant to develop a nanotechnology-enhanced biochip to help detect deadly diseases.
Read MorePosted by Cassandra Perez | Oct 17, 2017 | Cancer |
Megakaryocytes’ presence in prostate cancer linked to patient survival; such cells potentially have role in all cancer types.
Read MorePosted by Elaine Sanchez Wilson | Oct 2, 2017 | Digital Pathology |
Artificial intelligence is reshaping the capabilities and practices of modern pathology laboratories.
Read MorePosted by Elaine Sanchez Wilson | Aug 15, 2017 | Uncategorized |
Though not universal, it is an observable phenomenon that many in vitro diagnostic manufacturers and other suppliers to the clinical laboratory community schedule their product launches to coincide with the annual meeting of the American Association for Clinical Chemistry.
Read MorePosted by Elaine Sanchez Wilson | Aug 7, 2017 | Cancer, Controls, Quality Systems |
The updated control has received FDA premarket notification (510(k)) clearance and CE marking, and is available for the immunoassay-based tumor marker testing market.
Read More